Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemiballismus.

Comella1, Shannon

  • 1Department of Neurological Sciences, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison, Chicago, IL 60612, USA.

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arrhythmias in Congenital Heart Disease.

Current treatment options in cardiovascular medicine·2000
Same author

Neonatal bradycardia.

Progress in pediatric cardiology·2000
Same author

Eye and face in syndromes - the clinical examination of eyes and their surroundings

Journal of medical genetics·2000
Same author

Hormonal Control of Gene Expression During Reactivation of the Cell Cycle in Tobacco Mesophyll Protoplasts.

Journal of plant growth regulation·1999
Same author

Percolation of core melts at lower mantle conditions

Science (New York, N.Y.)·1998
Same author

Efficacy and Safety of Nifedipine Coat-Core versus Amlodipine in Patients With Mild to Moderate Essential Hypertension: Comparison of 24-Hour Mean Ambulatory Diastolic Blood Pressure.

Journal of cardiovascular pharmacology and therapeutics·1997
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Hemiballismus, a rare movement disorder affecting the subthalamic nucleus, is now treatable with pharmacologic advances and supportive care. Most patients survive and movements often resolve spontaneously within months.

Area of Science:

  • Neurology
  • Movement Disorders
  • Neuroscience

Background:

  • Hemiballismus is a rare, potentially life-threatening movement disorder.
  • Pathology involves the subthalamic nucleus and its connections.
  • Historically, prognosis was poor without effective treatments.

Purpose of the Study:

  • To review the pathophysiology and treatment of hemiballismus.
  • To highlight advances in pharmacologic management and supportive care.
  • To discuss the role of surgical intervention.

Main Methods:

  • Literature review of hemiballismus pathophysiology and treatment.
  • Analysis of historical and current treatment outcomes.
  • Evaluation of pharmacologic and surgical management strategies.

Related Experiment Videos

Main Results:

  • Pharmacologic treatments and supportive measures have significantly improved patient survival.
  • Hemiballismus movements often diminish or resolve spontaneously over several months.
  • Surgical treatment is a promising option for refractory cases.

Conclusions:

  • Modern management has transformed the prognosis for hemiballismus patients.
  • Vigorous acute-phase treatment is crucial, with potential for discontinuation after 6-12 months.
  • Surgery is reserved for persistent, medically refractory hemiballismus.